STAAR Surgical Company
STAA
$18.84
$0.452.45%
NASDAQ
| 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Revenue | -23.72% | -32.42% | -32.59% | -14.44% | -2.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -23.72% | -32.42% | -32.59% | -14.44% | -2.64% |
| Cost of Revenue | -23.27% | -16.95% | -8.13% | 3.51% | 6.53% |
| Gross Profit | -23.86% | -36.60% | -38.99% | -19.35% | -5.17% |
| SG&A Expenses | -9.23% | -1.47% | 4.33% | 10.76% | 14.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.59% | -6.56% | 0.29% | 7.41% | 11.46% |
| Operating Income | -270.38% | -329.11% | -391.31% | -281.88% | -141.57% |
| Income Before Tax | -808.78% | -362.54% | -441.08% | -329.12% | -126.86% |
| Income Tax Expenses | -116.27% | -66.61% | -119.22% | -14.95% | -9.66% |
| Earnings from Continuing Operations | -298.10% | -542.54% | -673.47% | -564.64% | -194.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -298.10% | -542.54% | -673.47% | -564.64% | -194.66% |
| EBIT | -270.38% | -329.11% | -391.31% | -281.88% | -141.57% |
| EBITDA | -585.58% | -263.19% | -319.40% | -223.23% | -115.67% |
| EPS Basic | -296.76% | -540.46% | -667.84% | -557.42% | -193.33% |
| Normalized Basic EPS | -304.02% | -258.82% | -329.80% | -235.25% | -125.36% |
| EPS Diluted | -292.72% | -545.61% | -672.43% | -569.09% | -196.92% |
| Normalized Diluted EPS | -296.53% | -261.90% | -333.18% | -238.31% | -126.56% |
| Average Basic Shares Outstanding | 0.89% | 0.87% | 0.96% | 1.12% | 1.24% |
| Average Diluted Shares Outstanding | 0.74% | 0.50% | 0.27% | 0.57% | 0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |